FFC#26/2015

Outcomes of spontaneous application of carrier screening for cystic fibrosis: follow-up of its effects on birth prevalence, neonatal screening and reproductive behaviour of carrier couples

AREA 5 Clinical and Epidemiological research

FFC#26/2015

Outcomes of spontaneous application of carrier screening for cystic fibrosis: follow-up of its effects on birth prevalence, neonatal screening and reproductive behaviour of carrier couples
€ 0 still needed
0%
€ 37.000 goal

pRINCIPAL INVESTIGATOR

Carlo Castellani (Centro Fibrosi Cistica – Azienda Ospedaliera Universitaria Integrata di Verona)

Researchers

4

Category

AREA 5 Clinical and Epidemiological research

Duration

3 years

Goal

€ 37.000

Funds raised

€ 37.000

Objectives

Children with CF are born of two parents carrying a CF mutation, who have a 1 in 4 risk of having a child with CF for each pregnancy. Testing for CF mutations and finding most CF carriers is nowadays possible, so that people can be informed of their risk of having an affected child. In the latest years the offer of an almost free of charge CF carrier test to individuals and couples with no affected relatives (carrier screening) has been widely practiced in part of north‐eastern Italy (Eastern Veneto), and that has led to a reduction in the number of births of babies with CF.
This study will continue and complete the previous FFC 8/11 project by collecting data on the number of carriers and carrier couples detected and on the correlation between these data and both disease incidence and newborn screening performance. In addition, information on the behaviour of couples of carriers identified by the screening system will be collected. This will allow to understand better if and how the reproductive choices of these couples affect the number of CF births.

WHO ADOPTED THE PROJECT

Gruppo di Sostegno FFC di Lainate

€ 10.000

Delegazione FFC di Pomezia Roma con Sara e Andrea

€ 15.000

Associazione Trentina Fibrosi Cistica in ricordo di Gianfranco BertaminI

€ 12.000

OTHER PROJECTS

Discover the other projects

GMSG#1/2025

Developing PNAs to Block Essential Bacterial Genes and Create New Antimicrobial Therapies

FFC#1/2025

Understanding the process of epithelial-mesenchymal transition to preserve tissue function and reduce long-term complications (e.g. cancer)

FFC#2/2025

Developing RNA-targeted therapies to regulate gene expression and restore CFTR synthesis